CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.

Br J Cancer · 2013 · PMC3817317 · PMID 24129241

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

borderline significantP= 0.058so close (0.05 < p ≤ 0.1)

The difference in the overall distribution of the outcomes for the WT and Δ32 patients was borderline significant ( P= 0.058) when checked with the Kruskal–Wallis test that assumes a progressive enrichment of one genotype over the other in three ordered response classes (i.e., CR>PR>NR).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.